Clinical Trials Browser

Phase 1/2 × Carcinoma, Non-Small-Cell Lung × Etoposide × Clear all

NCT07472647 2026-03-16

SYS6090 Combination Therapy in Advanced Lung Cancer

Phase 1/2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma

NCT01642251 2023-05-06

Cisplatin and Etoposide With or Without Veliparib in Treating Patients With Extensive Stage Small Cell Lung Cancer

Phase 1/2 Completed

156 enrolled 13 charts

EndocrineThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Neuroendocrine, Carcinoma, Small Cell, Small Cell Lung Carcinoma

NCT01076231 2021-05-17

Proton Beam Radiation Therapy and Chemotherapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Can Be Removed By Surgery

Phase 1/2 Completed

34 enrolled 9 charts

Carcinoma, Non-Small-Cell Lung

NCT00589056 2020-04-24

Nelfinavir, Radiation Therapy, Cisplatin, and Etoposide in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery

Phase 1/2 Completed

55 enrolled 11 charts

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT01733589 2017-07-14

Recombinant Human Endostatin Continued Pumping Into Vein Combining With CCRT in Unresectable Stage III NSCLC

Phase 1/2 Completed

Carcinoma, Non-Small-Cell Lung

NCT00417248 2016-07-25

Cisplatin/Etoposide/Radiotherapy Followed by Consolidation Sorafenib for Inoperable Stage III Non-Small Cell Lung Cancer

Phase 1/2 Terminated

8 enrolled 4 charts

Carcinoma, Non-Small-Cell Lung

NCT01222572 2015-06-04

Stereotactic Boost for Locally Advanced Non-Small Cell Lung Cancer

Phase 1/2 Terminated

1 enrolled 4 charts

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms